This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Leadiant Biosciences Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Brian Dean Schreiber: Innovator in Fibrosis Treatment
Introduction
Brian Dean Schreiber is a notable inventor based in Oshkosh, WI (US). He has made significant contributions to the field of medical treatments, particularly in addressing conditions related to fibrosis and scleroderma. His innovative work has led to the development of a patent that holds promise for improving patient outcomes.
Latest Patents
Brian Dean Schreiber holds a patent for "Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma." This patent includes Adenosine Deaminase (ADA) and various polypeptides or peptides with ADA activity. The invention focuses on pharmaceutical compositions and methods aimed at preventing and treating scleroderma-associated vasculopathy, including proliferative and progressive obliterative vasculopathy. The patent also addresses the prevention or reduction of scleroderma progression, encompassing local, diffuse, and systemic forms of the disease. He has 1 patent to his name.
Career Highlights
Throughout his career, Brian has worked with several companies, including Leadiant Biosciences Ltd. and Unikeris Limited. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Brian has collaborated with notable professionals in his field, including Nadejda Soukhareva and Gianfranco Fornasini. These partnerships have enhanced his research and development efforts, leading to advancements in treatment methodologies.
Conclusion
Brian Dean Schreiber is a dedicated inventor whose work in fibrosis treatment showcases his commitment to improving healthcare. His patent reflects a significant step forward in the fight against scleroderma and related conditions.